ORKA’s main bet is by targeting psoriasis with ultra-durable biologics like ORKA-001 (IL-23) in Phase 2a and ORKA-002 (IL-17A ...
Webull (BULL) stock analysis: modest FCF valuation, ~20% margins, and growth via new products & global expansion. Read here ...
Tesla's Q4 2025 deliveries fell 16% YoY, likely due to the expiration of Federal EV tax credits. Click here to read why TSLA ...
US Energy Secretary Wright plans to talk with oil companies about rebuilding Venezuela’s energy industry but it is far from ...
The Institute for Supply Management (ISM) manufacturing purchasing managers index (PMI) came in at 47.9 in December, the ...
Niagen Bioscience continues to see improving demand for Tru Niagen, strengthening cash generation, and a debt-free balance ...
Versant Media Group, Inc. debuts post-spin with $5.8B equity valuation and a compelling FCF yield near 20%. Learn more about ...
Q4 is expected to slow compared to the stellar 17.1% gain in Q4 '24, but 2026 should remain strong. Q1 estimates indicate ...
PicPay ( PICS ), a Brazlian mobile banking app, filed for a U.S. initial public offering, reporting that its profit surged 82 ...
Annaly Capital maintains a conservative balance sheet, strict leverage discipline, and outperformed peers in price recovery, ...
Jefferies Financial Group (JEF) is pushing to question Patrick James, the founder and former CEO of bankrupt auto parts ...
UMH Properties stock: a compelling buy with 5.7% dividend yield, below-average valuation, and strong NOI/FFO growth. Read the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results